PDCD1 and cancer: Using the top LINC01198-regulated genes, we constructed a LINC01198 activation score (see Materials and Methods) and evaluated whether it can predict immunotherapy response in 63 patients with cancer who received anti–PD-1 treatment (see Materials and Methods) (41, 42).